ACADIA Pharmaceuticals to Present at the JMP Securities Life Sciences Conference on June 24, 2015

SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced that it will present at the JMP Securities Life Sciences Conference on Wednesday, June 24, 2015, at 11:00 a.m. Eastern Time in New York City. A live webcast of ACADIA’s presentation will be accessible on the company’s website, www.acadia-pharm.com, under